Best for
Mobile
How to buy ValiRx shares
Own ValiRx shares in just a few minutes.
ValiRx plc is a biotechnology business based in the UK. ValiRx shares (VAL.LSE) are listed on the London Stock Exchange (LSE) and all prices are listed in pence sterling. ValiRx employs 11 staff and has a market cap (total outstanding shares value) of £16.4 million.
How to buy shares in ValiRx
- Choose a platform. If you're a beginner, our share-dealing table below can help you choose.
- Open your account. You'll need your ID, bank details and national insurance number.
- Confirm your payment details. You'll need to fund your account with a bank transfer, debit card or credit card.
- Search the platform for stock code: VAL in this case.
- Research ValiRx shares. The platform should provide the latest information available.
- Buy your ValiRx shares. It's that simple.
ValiRx share price
Use our graph to track the performance of VAL stocks over time.ValiRx shares at a glance
Information last updated 2021-01-24.
| Latest market close | N/Ap |
|---|---|
| 52-week range | 2.65p - 73p |
| 50-day moving average | 22.9848p |
| 200-day moving average | 20.9117p |
| Wall St. target price | 6p |
| Dividend yield | N/A (0%) |
| Earnings per share (TTM) | -0.5p |
Invest in ValiRx shares with 0% commission
Other fees may apply. Your capital is at risk.
- Unlimited trades, with no dealing charges or management fees
- If your trades get copied you can earn extra money
- Create an account today in a few minutes
Go to site
Capital at risk
Share dealing platform comparison
Table: sorted by promoted deals first
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is it a good time to buy ValiRx stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
ValiRx financials
| Gross profit TTM | £0 |
|---|---|
| Return on assets TTM | -40.66% |
| Return on equity TTM | -80.46% |
| Profit margin | 0% |
| Book value | 0.081p |
| Market capitalisation | £16.4 million |
TTM: trailing 12 months
ValiRx share dividends
We're not expecting ValiRx to pay a dividend over the next 12 months. However, you can browse other dividend-paying shares in our guide.
Have ValiRx's shares ever split?
ValiRx's shares were split on a 1:125 basis on 6 April 2020. So if you had owned 125 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your ValiRx shares – just the quantity. However, indirectly, the new 12400% higher share price could have impacted the market appetite for ValiRx shares which in turn could have impacted ValiRx's share price.
ValiRx share price volatility
Over the last 12 months, ValiRx's shares have ranged in value from as little as 2.65p up to 73p. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (LSE average) beta is 1, while ValiRx's is 2.024. This would suggest that ValiRx's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Win £500 to get your trading started
Subscribe to trending stock alerts for a chance to win
ValiRx overview
ValiRx plc, a biotechnology oncology focused company, engages in developing novel therapeutics and associated biomarkers for cancer in the United Kingdom. The company's lead drug candidates include VAL201, an anti-cancer therapeutic that is in Phase I/II trials for the treatment of prostate cancer and other indications of hormone induced unregulated growth, including endometriosis; VAL301, a reformulation of VAL201, which is in pre-clinical development for the treatment of women with endometriosis; and VAL401, a reformulation of generic drug Risperidone, which has completed Phase II clinical trial for the treatment of non-small cell lung cancer. Its drug candidates also comprise VAL101, a candidate produced by GeneICE technology platform to modulate BCl2 expression ? implicated in cancers. ValiRx plc has collaboration agreement with Oncolytika Limited and Black Cat Bio Limited to develop and evaluate BC201 for patients suffering a hyperimmune response to Coronavirus SARS-CoV2 infection. The company was incorporated in 2000 and is based in Hatfield, the United Kingdom.
Frequently asked questions
More guides on Finder
-
How to buy ValiRx shares
Learn more about Transportation and Logistics Systems’ recent performance and where you can invest in Transportation and Logistics Systems shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Charlie’s Holdings shares
Learn more about Charlie’s Holdings’ recent performance and where you can invest in Charlie’s Holdings shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Lemonade shares
Learn more about Lemonade’s recent performance and where you can invest in Lemonade shares. We also run through some helpful rules of thumb for any investor.
-
How to buy Unity Software shares
Learn more about Unity Software’s recent performance and where you can invest in Unity Software shares. We also run through some helpful rules of thumb for any investor
-
How to buy FuelCell Energy shares
Learn more about FuelCell Energy’s recent performance and where you can invest in FuelCell Energy shares. We also run through some helpful rules of thumb for any investor.
-
How to buy ValiRx shares
Learn more about CloudCommerce’s recent performance and where you can invest in CloudCommerce shares. We also run through some helpful rules of thumb for any investor
-
How to buy Zomedica Pharmaceuticals shares
Ever wondered how to buy shares in Zomedica Pharmaceuticals? We explain how and compare a range of providers that can give you access to many brands, including Zomedica Pharmaceuticals.
-
How to buy YRC Worldwide shares
Ever wondered how to buy shares in YRC Worldwide? We explain how and compare a range of providers that can give you access to many brands, including YRC Worldwide.
-
How to buy Xeros Technology Group shares
Ever wondered how to buy shares in Xeros Technology Group? We explain how and compare a range of providers that can give you access to many brands, including Xeros Technology Group.
-
How to buy Xpediator shares
Ever wondered how to buy shares in Xpediator? We explain how and compare a range of providers that can give you access to many brands, including Xpediator.
Ask an Expert